Easing the Disease Burden of Patients with Atopic Dermatitis

Annenberg Center for Health Sciences
  • 0.0 (0)
  • MEDICINE

Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to

Episodes

  1. 11/01/2021

    Emerging Therapies: Phase 3 Efficacy & Safety Data

    JAK-STAT inhibitors: oral and topical JAK-STAT inhibitors vs dupilumab IL-13 antagonists IL-31 antagonists

    17 min

  2. 11/01/2021

    AD Therapies Approved After 2014 AAD Guidelines

    Mechanism of action, indication, efficacy, and safety Dupilumab Crisaborole

    12 min

  3. 11/01/2021

    Adherence to Evidence-Based Guidelines

    2014 AAD Guidelines Recommendations for topical therapies Recommendations for phototherapy

    6 min

  4. 11/01/2021

    Components of Basic AD Care

    Role of bathing and moisturizers Role of topical corticosteroids

    4 min
  5. Unmet Needs in AD Care

    11/01/2021

    Unmet Needs in AD Care

    Direct and indirect effects of AD Discordance in disease burden between providers and patients Rates of inadequate disease control

    5 min
  • 5 Episodes

About

Atopic dermatitis (AD) is a skin condition with substantial direct and indirect effects on patients. Guidelines for the management of AD were published in 2014, and while many of the tenets of basic AD skin care are well established, patients with AD are still not achieving optimal disease control in real-world practice. In this activity, Dr. Jonathan Silverberg reviews the burden of AD and the unmet needs within AD management today. Components of basic skin care from the 2014 guidelines are reviewed, followed by the most recent data supporting approved therapies and newly emerging oral and to

Information